JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 2 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.45B |
| 3 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.34B |
| 4 |
EA
Electronic Arts
EA
|
+$903M |
| 5 |
Automatic Data Processing
ADP
|
+$825M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.63B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.06B |
| 3 |
Meta Platforms (Facebook)
META
|
+$942M |
| 4 |
Nike
NKE
|
+$779M |
| 5 |
Union Pacific
UNP
|
+$543M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.97% |
| 2 | Technology | 12.33% |
| 3 | Healthcare | 10.23% |
| 4 | Consumer Discretionary | 8.25% |
| 5 | Industrials | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WAAS
4301
DELISTED
AquaVenture Holdings Limited
WAAS
| $331K | ﹤0.01% |
18,295
-20,118
| -52% | -$343K |
|
4302
Brookfield Renewable
BEP
$10.3B
| $329K | ﹤0.01% |
20,454
+10,884
| +114% | +$179K |
|
|
NBIS
4303
CALL
Nebius Group N.V.
NBIS
$70.5B
| $329K | ﹤0.01% |
10,000
| – | – |
|
4304
Harrow
HROW
$1.48B
| $328K | ﹤0.01% |
117,990
+60,248
| +104% | +$163K |
|
4305
ALPS O'Shares U.S. Quality Dividend ETF
OUSA
$758M
| $328K | ﹤0.01% |
10,000
-31
| -0.3% | -$993 |
|
4306
Cohen & Steers Duration Preferred & Income Fund
LDP
$599M
| $326K | ﹤0.01% |
13,689
+11,609
| +558% | +$288K |
|
4307
Marcus & Millichap
MMI
$1.18B
| $325K | ﹤0.01% |
9,382
+5,433
| +138% | +$206K |
|
|
SEI
4308
Solaris Energy Infrastructure
SEI
$4.07B
| $325K | ﹤0.01% |
17,231
-58
| -0.3% | -$931 |
|
|
IBTX
4309
DELISTED
Independent Bank Group, Inc.
IBTX
| $325K | ﹤0.01% |
4,896
+604
| +14% | +$41.2K |
|
|
CLPR
4310
Clipper Realty
CLPR
$50.9M
| $322K | ﹤0.01% |
23,756
+20,677
| +672% | +$231K |
|
4311
nLIGHT
LASR
$3.06B
| $322K | ﹤0.01% |
14,527
+9,913
| +215% | +$310K |
|
|
DFBG
4312
DELISTED
Differential Brands Group Inc
DFBG
| $322K | ﹤0.01% |
+79,300
| New | +$380K |
|
4313
Fortress Biotech
FBIO
$91.4M
| $321K | ﹤0.01% |
13,392
+9,717
| +264% | +$311K |
|
4314
CALL
Rigel Pharmaceuticals
RIGL
$782M
| $321K | ﹤0.01% |
+10,000
| New | +$300K |
|
|
4315
PUT
Rigel Pharmaceuticals
RIGL
$782M
| $321K | ﹤0.01% |
+10,000
| New | +$300K |
|
4316
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.59B
| $320K | ﹤0.01% |
13,968
+1,350
| +11% | +$30.1K |
|
4317
UroGen Pharma
URGN
$2.39B
| $320K | ﹤0.01% |
+6,778
| New | +$315K |
|
4318
Codexis
CDXS
$175M
| $319K | ﹤0.01% |
18,639
+8,299
| +80% | +$134K |
|
4319
VanEck Energy Income ETF
EINC
$79.5M
| $318K | ﹤0.01% |
4,848
+4,045
| +504% | +$268K |
|
4320
FormFactor
FORM
$10.1B
| $317K | ﹤0.01% |
23,032
-111,377
| -83% | -$1.54M |
|
4321
Opko Health
OPK
$1.04B
| $317K | ﹤0.01% |
91,775
-14,818
| -14% | -$78.7K |
|
|
XENT
4322
DELISTED
Intersect ENT, Inc
XENT
| $317K | ﹤0.01% |
11,027
-841
| -7% | -$25.3K |
|
4323
Natural Health Trends
NHTC
$15.4M
| $316K | ﹤0.01% |
13,574
+12,078
| +807% | +$296K |
|
4324
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.22B
| $315K | ﹤0.01% |
4,664
+983
| +27% | +$66.1K |
|
|
HTZ
4325
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $315K | ﹤0.01% |
22,236
+6,414
| +41% | +$96.4K |
|
Similar funds
JP Morgan Chase's Q3 2018 Portfolio in Review
As of Q3 2018, JP Morgan Chase held 6,019 positions worth $522B, up 7.4% from $486B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q3 2018 filing shows 449 new, 2,597 increased, 2,100 reduced and 313 closed positions. Its largest new stake was JPMorgan BetaBuilders Canada ETF: 29,437,708 shares worth $1.45B. The largest sale was Broadcom, an estimated $1.63B.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q3 2018 buy was JPMorgan BetaBuilders Canada ETF: 29,437,708 shares worth $1.45B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Japan ETF in Q3 2018, an estimated $1.83B increase.
- JP Morgan Chase's biggest Q3 2018 reduction was Broadcom, cutting an estimated $1.63B.
- JP Morgan Chase fully exited Cavium, Inc. in Q3 2018, selling an estimated $316M.
- JP Morgan Chase's ten largest holdings make up 18% of its $522B portfolio in Q3 2018.
- JP Morgan Chase opened 449 new positions and closed 313 in Q3 2018.
- JP Morgan Chase's portfolio value rose 7.4% quarter-over-quarter to $522B.
Based on JP Morgan Chase's 13F filing for Q3 2018, filed 7 Nov 2018.